News FDA Releases Updated Guidance on Controlling Nitrosamine Impurities in Human Drugs 5 September 2024 gmpinsiders FDA's 2024 guidance on nitrosamine impurities introduces new limits, testing methods, and timelines, focusing on NDSRIs to enhance drug safety and compliance.
